Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Preparation of Linearity Data Table – V 2.0

Posted on By

Analytical Method Development: SOP for Preparation of Linearity Data Table – V 2.0

Standard Operating Procedure for Preparation of Linearity Data Table in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/310/2025
Supersedes SOP/AMD/310/2022
Page No. Page 1 of 11
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

The purpose of this SOP is to define the standardized procedure for preparing a linearity data table as part of analytical method development and validation. It includes

steps for sample preparation, data recording, regression analysis, and documentation to demonstrate the method’s ability to produce results that are directly proportional to the concentration of analyte across a specified range.

2. Scope

This procedure is applicable to all analytical methods under development within the Analytical Method Development (AMD) department for assay, related substances, dissolution, and content uniformity methods. It is applicable for both chromatographic and non-chromatographic techniques.

3. Responsibilities

  • Analyst: Prepares solutions, performs injections, and records responses.
  • Data Reviewer: Reviews linearity data, verifies calculations, and confirms compliance with acceptance criteria.
  • QA Personnel: Ensures the documented data table is audit-ready and conforms with ICH and GMP requirements.
See also  Analytical Method Development: Stability-Indicating Method Development - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring the accuracy, completeness, and compliance of linearity evaluations and associated data tables as part of method validation reports.

5. Procedure

5.1 Preparation of Linearity Solutions

  1. Select a concentration range typically from 50% to 150% of the target concentration. Include a minimum of 5 concentration levels (e.g., 50%, 75%, 100%, 125%, 150%).
  2. Prepare each concentration level using a validated dilution technique and record dilution factors.
  3. Label and store the linearity samples appropriately as per stability data.

5.2 Data Collection

  1. Inject each level (preferably in triplicate) into the chromatographic system or record absorbance/response.
  2. Ensure system suitability parameters are met before proceeding with linearity injections.
  3. Record retention time (if applicable), area, and response for each injection in a raw data sheet.

5.3 Preparation of Linearity Data Table

  1. Create a structured table with the following columns:
    • Concentration (% of target)
    • Theoretical Concentration (μg/mL)
    • Peak Area or Response
    • Average Response
    • Standard Deviation
    • Relative Standard Deviation (RSD%)
  2. Calculate average area and % RSD for each concentration level.
  3. Plot Concentration vs. Average Area or Response to generate the calibration curve.
See also  Analytical Method Development: Disinfectant Effectiveness Test Method - V 2.0

5.4 Regression Analysis

  1. Perform linear regression using suitable software (e.g., Microsoft Excel, Empower, or validated LIMS software).
  2. Calculate:
    • Slope (m)
    • Intercept (c)
    • Coefficient of Determination (R²)
  3. Acceptable criteria:
    • R² ≥ 0.998 for assay methods
    • R² ≥ 0.990 for impurity methods

5.5 Documentation and Evaluation

  1. Attach printouts of chromatograms or spectrophotograms for each level.
  2. Include the regression equation and linearity graph in the method validation report.
  3. Document any observations related to carryover, peak distortion, or baseline drift.

6. Abbreviations

  • RSD: Relative Standard Deviation
  • QA: Quality Assurance
  • ICH: International Council for Harmonisation
  • LOD: Limit of Detection
  • LOQ: Limit of Quantitation

7. Documents

  1. Linearity Calculation Sheet – Annexure-1
  2. Chromatograms/Spectra Records – Annexure-2
  3. Regression Analysis Summary – Annexure-3

8. References

  • ICH Q2(R1) – Validation of Analytical Procedures: Text and Methodology
  • FDA Guidance for Industry – Analytical Procedures and Methods Validation
  • 21 CFR Part 211 – Current Good Manufacturing Practice
See also  Analytical Method Development: SOP for Qualification of HPLC System - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Swati Mehra Karan Vyas Dr. Harshita Goyal
Designation Analyst – AMD QA Reviewer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Linearity Calculation Sheet

Conc. (%) Theoretical Conc. (μg/mL) Avg. Area SD RSD (%)
50 10 10235 45 0.44
75 15 15410 60 0.39
100 20 20580 80 0.39
125 25 25740 92 0.36
150 30 30790 110 0.36

Annexure-2: Chromatograms/Spectra

Attach all raw data printouts or electronic files from HPLC or UV systems used in linearity evaluation.

Annexure-3: Regression Analysis Summary

Linearity Equation: y = 1023.6x + 50.2
R² = 0.9991
Slope and intercept within expected range based on method requirements.

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Expanded linearity procedure and included annexure formats Annual SOP Review Dr. Harshita Goyal
15/03/2022 1.0 Initial version New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Aligning SOP Updates With Regulatory Guidance Documents
Next Post: Elixir Department: SOP for Limit Test for Chloride and Sulfates – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version